Conquering Diseases

Study Of An Investigational Drug Combination For Advanced Ovarian, Fallopian Tube Or Peritoneal Cancer

Description

Seeking women with advanced ovarian, fallopian tube or peritoneal cancer who have, or will have "debulking" surgery to remove as much of their cancer as possible for a study of an investigational drug given in combination with the usual post-surgery chemotherapy with paclitiaxel and carboplatin.

Overview

Participants in this study will be randomly assigned to receive either the investigational drug or a placebo (looks like the drug, but contains no medicine). All participants will receive chemotherapy with paclitiaxel and carboplatin.

What we're hoping for

We are studying whether adding an investigational drug to the usual chemotherapy following surgery to remove advanced ovarian, fallopian tube or peritoneal cancer helps extend the time before the cancer returns.

Additional Information

ClinicalTrials.gov Identifier: NCT04498117

 Principal Investigator

Susan  Zweizig, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989